Infectious bovine keratoconjunctivitis, commonly known as pinkeye, is a highly contagious bacterial eye disease affecting cattle worldwide that causes significant economic losses to beef and dairy industries annually. The disease is characterized by inflammation of the cornea and conjunctiva, progressing from initial tearing and sensitivity to light through corneal ulceration that can lead to permanent scarring and blindness if left untreated. Pinkeye spreads rapidly through cattle populations, particularly during summer months when face flies are active, making outbreaks difficult to control once established in a herd.
The disease affects cattle of all ages and breeds, though certain populations demonstrate markedly higher susceptibility. Cattle with unpigmented skin around their eyes, particularly Herefords and Hereford crosses, experience higher incidence and more severe disease than breeds with pigmented periocular skin. Young cattle encountering the causative bacteria for the first time often develop more severe disease than previously exposed adults with some acquired immunity. Both beef and dairy cattle are susceptible, with confined cattle and those on pastures with tall grass or weedy vegetation showing elevated risk due to increased eye irritation and fly exposure.
The economic impact of infectious bovine keratoconjunctivitis extends far beyond treatment costs to include reduced weight gains, decreased milk production, lower breeding efficiency, and diminished sale value of visibly affected animals. Studies estimate annual losses to the United States cattle industry alone exceed 150 million dollars when all direct and indirect costs are considered. Animals with active infections show reduced feed intake, and the pain and visual impairment cause affected cattle to separate from the herd and fail to thrive. Permanent corneal scarring from healed infections reduces market value and may impair breeding soundness in bulls requiring good depth perception.
Despite the significant impact of pinkeye, effective prevention and treatment options exist that can minimize disease severity and spread within affected herds. Vaccines, while imperfect, reduce disease severity and should be part of comprehensive prevention programs in endemic areas. Prompt treatment of affected individuals with appropriate antibiotics limits corneal damage and reduces shedding of bacteria that infects susceptible herdmates. Environmental management targeting fly populations and reducing eye irritation helps break transmission cycles. Integrated approaches combining vaccination, treatment, and environmental control provide the best outcomes for managing this challenging disease.
